Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Poradosu Enrique, Autre. Officer active across 1 company, notably Nuvectis Pharma, Inc.. Aggregated, 10 disclosures have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €34k. Activity tracked since 4 February 2022. The latest transaction was disclosed on 6 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Poradosu Enrique
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3,800 shares@ US$3.350.0038% mcap40.4% of flowCommon Stock, par value $0.00001SEC:0001104659-22-014376:0
Canonical exit: 5 May 2022 (T+90)
10 of 10 declarations
About Poradosu Enrique
Poradosu Enrique is the Chief Science & Business Officer at Nuvectis Pharma, Inc. In this role, he oversees the company's scientific and business initiatives, contributing to its strategic development. His expertise is essential in aligning scientific objectives with business opportunities.